浙江诚意药业股份有限公司关于以集中竞价方式回购公司股份的进展公告

Group 1 - The company plans to repurchase shares using a budget of no less than RMB 50 million and no more than RMB 100 million, intended for equity incentives or employee stock ownership plans [2] - The repurchase period is set for 12 months from the date of the board's approval of the share repurchase plan [2] - As of July 31, 2025, the company has repurchased a total of 9,618,796 shares, representing 2.94% of the total share capital, with a total expenditure of RMB 76,397,831.64 [3] Group 2 - The highest transaction price during the repurchase was RMB 8.36 per share, while the lowest was RMB 7.25 per share [3] - The company will adhere to relevant regulations and guidelines during the repurchase process and will disclose progress in a timely manner [4]